Bülent Polat

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

Cancers

Materials (Basel, Switzerland)

Cancer cell international

Immunotherapy

University Hospital of Würzburg

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital of Würzburg Mar 01 2005

Germany

MD :: Department of Radiation Oncology

Publications

Dominik Lisowski, Paul Lutyj, Arya Abazari, Stefan Weick, Jan Traub, Bülent Polat, Michael Flentje, Johannes Kraft
Impact of Radiotherapy on Malfunctions and Battery Life of Cardiac Implantable Electronic Devices in Cancer Patients. Cancers 15 (19) (2023)
Jörg Tamihardja, Leonie Zehner, Philipp E Hartrampf, Sinan Cirsi, Sonja Wegener, Andreas K Buck, Michael Flentje, Bülent Polat
Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era. Cancers 14 (19) (2022)
Markus Diefenhardt, Daniel Martin, Ethan Bernard Ludmir, Maximilian Fleischmann, Ralf-Dieter Hofheinz, Michael Ghadimi, Rebekka Kosmala, Bülent Polat, Tim Friede, Bruce D Minsky, Claus Rödel, Emmanouil Fokas
Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial. Cancers 14 (18) (2022)
Jörg Tamihardja, Leonie Zehner, Philipp E Hartrampf, Dominik Lisowski, Susanne Kneitz, Sinan Cirsi, Gary Razinskas, Michael Flentje, Bülent Polat
Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up. Cancers 14 (15) (2022)
Bülent Polat, Gisela Wohlleben, Rebekka Kosmala, Dominik Lisowski, Frederick Mantel, Victor Lewitzki, Mario Löhr, Robert Blum, Petra Herud, Michael Flentje, Camelia-Maria Monoranu
Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma. Cancer cell international 22 (1) (2022)
Horst-Dieter Hummel, Peter Kufer, Carsten Grüllich, Ruth Seggewiss-Bernhardt, Barbara Deschler-Baier, Manik Chatterjee, Maria-Elisabeth Goebeler, Kurt Miller, Maria de Santis, Wolfgang Loidl, Christian Dittrich, Andreas K Buck, Constantin Lapa, Annette Thurner, Sabine Wittemer-Rump, Gökben Koca, Oliver Boix, Wolf-Dietrich Döcke, Ricarda Finnern, Helena Kusi, Antoinette Ajavon-Hartmann, Sabine Stienen, Cyrus Michael Sayehli, Bülent Polat, Ralf Christian Bargou
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings. Immunotherapy 13 (2) (2020)
Till Jasper Meyer, Agmal Scherzad, Helena Moratin, Thomas Eckert Gehrke, Julian Killisperger, Rudolf Hagen, Gisela Wohlleben, Bülent Polat, Sofia Dembski, Norbert Kleinsasser, Stephan Hackenberg
The Radiosensitizing Effect of Zinc Oxide Nanoparticles in Sub-Cytotoxic Dosing Is Associated with Oxidative Stress In Vitro. Materials (Basel, Switzerland) 12 (24) (2019)

Bülent Polat.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bülent Polat